A lack of effective non-invasive ways to diagnose endometriosis contributes to delayed intervention and limits the potential for clinical development of therapeutics. Credit: H_Ko/Shutterstock.com.

As ADC pipelines expand rapidly, innovations in payload linker chemistry are becoming a key enabler of next-generation ...

Daiichi Sankyo has collaborated with Tempus AI to expedite the clinical development and differentiation of an ADC programme ...

At the 2026 ACC Scientific Session in New Orleans, researchers presented a meta-analysis of three randomized trials (1,264 ...

Biocytogen has entered a strategic partnership with Sihuan Pharmaceutical to advance new therapeutics across several disease areas.

Merck KGaA has completed its previously announced acquisition of the chromatography business of JSR Life Sciences.

Blackstone says this is the largest private life sciences fund ever raised, which will support innovation in pharma and medtech.

Viz.ai has entered a collaboration with Alnylam to advance earlier identification and streamline diagnosis for cardiac ...

Telomir Pharmaceuticals has submitted an IND application to the FDA for Telomir-1, its lead candidate targeting advanced and metastatic TNBC.

GlobalData anticipates notable growth in the head and neck squamous cell carcinoma (HNSCC) market by 2034, at a CAGR of 8.4%.

The US Food and Drug Administration (FDA) will convene a public hearing intended to obtain feedback on its Commissioner’s ...

The UK must tackle commercial, funding and systemic challenges to fully harness its global life sciences, pharma and biotech potential.